87 results
425
EX-99.1
THER
Theralink Technologies, Inc.
26 May 23
Business combination disclosure
5:14pm
effective treatment plan for their cancer patients.
Recently, Theralink received a Medicare reimbursement rate determination as well as added to its … access and reimbursement initiatives for our clinical patient testing, expand our product offering portfolio and research initiatives, and increase our
425
EX-2.1
gud0o65cxk31tmy5yjl
26 May 23
Business combination disclosure
5:14pm
8-K
EX-2.1
1ufnj
26 May 23
Theralink® Signs Definitive Merger Agreement to be Acquired by
5:11pm
8-K
EX-99.1
bsp71rdwmo67vh2qzq
26 May 23
Theralink® Signs Definitive Merger Agreement to be Acquired by
5:11pm
8-K
171wq 3x6
11 May 23
Departure of Directors or Certain Officers
5:00pm
8-K
96nyxejt2hbrw6
8 Dec 22
Theralink® Technologies Appoints Seasoned Commercial Leader, Faith Zaslavsky, as President & Chief
7:23pm
8-K
EX-99.1
ygc 0elym
8 Dec 22
Theralink® Technologies Appoints Seasoned Commercial Leader, Faith Zaslavsky, as President & Chief
7:23pm
8-K
EX-10.1
3hycc3cc3xcqx6uw7
1 Dec 22
Theralink® Technologies Announces Closing of Private Placement and Conversion of Existing Convertible Notes and Convertible Preferred Shares
5:15pm
8-K
EX-10.2
paz2n1
1 Dec 22
Theralink® Technologies Announces Closing of Private Placement and Conversion of Existing Convertible Notes and Convertible Preferred Shares
5:15pm
8-K
EX-10.1
tjk0xht
3 Feb 22
Entry into a Material Definitive Agreement
5:11pm